EMAS position statement: Bone densitometry screening for osteoporosis

Mark Brincat; Jean Calleja-Agius; C Tamer Erel; Marco Gambacciani; Irene Lambrinoudaki; Mette H Moen; Karin Schenck-Gustafsson; Florence Tremollieres; Svetlana Vujovic; Margaret Rees; Serge Rozenberg; EMAS

doi:10.1016/j.maturitas.2010.09.009

EMAS position statement: Bone densitometry screening for osteoporosis

Maturitas. 2011 Jan;68(1):98-101. doi: 10.1016/j.maturitas.2010.09.009. Epub 2010 Nov 19.

Authors

Mark Brincat¹, Jean Calleja-Agius, C Tamer Erel, Marco Gambacciani, Irene Lambrinoudaki, Mette H Moen, Karin Schenck-Gustafsson, Florence Tremollieres, Svetlana Vujovic, Margaret Rees, Serge Rozenberg; EMAS

Affiliation

¹ Department of Obstetrics and Gynaecology, Mater Dei Hospital, BKR 2090 B’Kara, Malta. [email protected]

PMID: 21093180
DOI: 10.1016/j.maturitas.2010.09.009

Abstract

Introduction: Osteoporosis and its consequent fractures is a major public health problem.

Aim: To formulate a position statement on the use of bone densitometry in screening postmenopausal women for osteoporosis and in their management.

Materials and methods: Literature review and consensus of expert opinion.

Results and conclusions: Bone densitometry has an important role in screening postmenopausal women for osteoporosis. For higher sensitivity and specificity, there may be a stronger case for screening in later life, depending on the extent to which risk factors add to the value of bone mineral density tests.

Publication types

Practice Guideline

MeSH terms

Age Factors
Bone Density*
Densitometry / methods*
Female
Humans
Mass Screening / methods*
Osteoporosis, Postmenopausal / diagnosis*
Sensitivity and Specificity